These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29258062)

  • 1. Phage Abp1 Rescues Human Cells and Mice from Infection by Pan-Drug Resistant Acinetobacter Baumannii.
    Yin S; Huang G; Zhang Y; Jiang B; Yang Z; Dong Z; You B; Yuan Z; Hu F; Zhao Y; Peng Y
    Cell Physiol Biochem; 2017; 44(6):2337-2345. PubMed ID: 29258062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
    Jeon J; Park JH; Yong D
    BMC Microbiol; 2019 Apr; 19(1):70. PubMed ID: 30940074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii.
    Yuan Y; Wang L; Li X; Tan D; Cong C; Xu Y
    Virus Res; 2019 Oct; 272():197734. PubMed ID: 31465789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357.
    Jeon J; Ryu CM; Lee JY; Park JH; Yong D; Lee K
    Appl Environ Microbiol; 2016 Jul; 82(14):4200-4208. PubMed ID: 27208124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a lytic bacteriophage against extensively drug-resistant Acinetobacter baumannii infections and its dramatic effect in rat model of burn infection.
    Ghaznavi-Rad E; Komijani M; Moradabadi A; Rezaei M; Shaykh-Baygloo N
    J Clin Lab Anal; 2022 Jul; 36(7):e24497. PubMed ID: 35708005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal treatment with bacteriophage rescues mice from Acinetobacter baumannii-mediated pneumonia.
    Wang Y; Mi Z; Niu W; An X; Yuan X; Liu H; Li P; Liu Y; Feng Y; Huang Y; Zhang X; Zhang Z; Fan H; Peng F; Tong Y; Bai C
    Future Microbiol; 2016 May; 11():631-41. PubMed ID: 26925593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and Characterization of a Novel
    Wintachai P; Surachat K; Singkhamanan K
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characteristic and potential therapeutic effect of isolated multidrug-resistant Acinetobacter baumannii lytic phage.
    Sisakhtpour B; Mirzaei A; Karbasizadeh V; Hosseini N; Shabani M; Moghim S
    Ann Clin Microbiol Antimicrob; 2022 Jan; 21(1):1. PubMed ID: 34996464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii.
    Bagińska N; Pichlak A; Górski A; Jończyk-Matysiak E
    Virol Sin; 2019 Aug; 34(4):347-357. PubMed ID: 31093881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials.
    Gordillo Altamirano F; Forsyth JH; Patwa R; Kostoulias X; Trim M; Subedi D; Archer SK; Morris FC; Oliveira C; Kielty L; Korneev D; O'Bryan MK; Lithgow TJ; Peleg AY; Barr JJ
    Nat Microbiol; 2021 Feb; 6(2):157-161. PubMed ID: 33432151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of bacteriophage in resolving wound infection caused by multidrug-resistant Acinetobacter baumannii in uncontrolled diabetic rats.
    Shivaswamy VC; Kalasuramath SB; Sadanand CK; Basavaraju AK; Ginnavaram V; Bille S; Ukken SS; Pushparaj UN
    Microb Drug Resist; 2015 Apr; 21(2):171-7. PubMed ID: 25411824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics Act with vB_AbaP_AGC01 Phage against
    Grygorcewicz B; Roszak M; Golec P; Śleboda-Taront D; Łubowska N; Górska M; Jursa-Kulesza J; Rakoczy R; Wojciuk B; Dołęgowska B
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections.
    Regeimbal JM; Jacobs AC; Corey BW; Henry MS; Thompson MG; Pavlicek RL; Quinones J; Hannah RM; Ghebremedhin M; Crane NJ; Zurawski DV; Teneza-Mora NC; Biswas B; Hall ER
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5806-16. PubMed ID: 27431214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii.
    Yang H; Liang L; Lin S; Jia S
    BMC Microbiol; 2010 Apr; 10():131. PubMed ID: 20426877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of newly isolated and highly potent bacteriophages in a mouse model of extensively drug-resistant Acinetobacter baumannii bacteraemia.
    Leshkasheli L; Kutateladze M; Balarjishvili N; Bolkvadze D; Save J; Oechslin F; Que YA; Resch G
    J Glob Antimicrob Resist; 2019 Dec; 19():255-261. PubMed ID: 31100499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice].
    Deng LY; Yang ZC; Gong YL; Huang GT; Yin SP; Jiang B; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):523-8. PubMed ID: 27647067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Assessment of Bacteriophage Therapy against Experimental
    Wienhold SM; Brack MC; Nouailles G; Krishnamoorthy G; Korf IHE; Seitz C; Wienecke S; Dietert K; Gurtner C; Kershaw O; Gruber AD; Ross A; Ziehr H; Rohde M; Neudecker J; Lienau J; Suttorp N; Hippenstiel S; Hocke AC; Rohde C; Witzenrath M
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1).
    Huang G; Shen X; Gong Y; Dong Z; Zhao X; Shen W; Wang J; Hu F; Peng Y
    BMC Infect Dis; 2014 Dec; 14():681. PubMed ID: 25495514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of φkm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumannii.
    Shen GH; Wang JL; Wen FS; Chang KM; Kuo CF; Lin CH; Luo HR; Hung CH
    PLoS One; 2012; 7(10):e46537. PubMed ID: 23071586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of a lytic bacteriophage to disrupt Acinetobacter baumannii biofilms in vitro.
    Liu Y; Mi Z; Niu W; An X; Yuan X; Liu H; Wang Y; Feng Y; Huang Y; Zhang X; Zhang Z; Fan H; Peng F; Li P; Tong Y; Bai C
    Future Microbiol; 2016 Oct; 11():1383-1393. PubMed ID: 27538011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.